Listing Page

Category: Bulk Active Ingredient

Patent Cliff 2.0: How to Leverage the 351(k) Pathway for Biosimilars
More than $198 billion in global prescription drug sales are at risk from patent expirations between...
Read More >
Overcoming API Challenges for Novel Drug Delivery Systems
The 505(b)(2) regulatory pathway is an increasingly popular method of getting drug approval – and one...
Read More >